Welcome to European Tribune. It's gone a bit quiet around here these days, but it's still going.
Display:
Fauci reads notes on Phase I [?!] trial. Moderna stock up 25% in early trading.
by Cat on Mon May 18th, 2020 at 08:46:52 PM EST
[ Parent ]
Early data on Moderna's COVID-19 vaccine insufficient: Stat News
The news publication's report pulled down shares of the Cambridge, Massachusetts-based biotech and erased modest gains on the benchmark S&P 500 index. ...Moderna later announced a stock sale that could raise about $1.5 billion, sending shares lower early on Tuesday.
by Cat on Wed May 20th, 2020 at 01:37:37 AM EST
[ Parent ]
by Cat on Wed May 27th, 2020 at 10:01:52 PM EST
[ Parent ]
Inovio says COVID-19 vaccine produces antibodies in mice, guinea pigs
The company's shares, which have more than quadrupled this year on hopes of its vaccine working, SURGED another 18% to $15.77 early trading.
[...]
Inovio began human testing of its vaccine in April. ... Inovio said preliminary results from its human trial are expected in June. The 40 healthy participants in the Phase 1 trial are given two shots, four weeks apart, of the vaccine, called INO-4800, and then followed for two weeks.
archived Fri Feb 7th, 2020

Diversity is the key to economic and political evolution.
by Cat on Thu May 21st, 2020 at 11:04:49 AM EST
[ Parent ]
dispensing with clinical pretext

Diversity is the key to economic and political evolution.
by Cat on Thu May 21st, 2020 at 03:21:18 PM EST
[ Parent ]

U.S. secures 300 million doses of potential AstraZeneca COVID-19 vaccine, "previously known as ChAdOx1 nCoV-19 and now as AZD1222"
The U.S. deal allows a late-stage - Phase III - clinical trial of the vaccine with 30,000 people in the United States.


Diversity is the key to economic and political evolution.
by Cat on Thu May 21st, 2020 at 03:28:12 PM EST
[ Parent ]

Display:

Occasional Series